UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of incorpo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of ...

DURECT Corporation (NASDAQ:DRRX) Q4 2019 Results Earnings Conference Call March 3, 2020 4:30 PM ET Company Participants Mike Arenberg - Chief Financial Officer Jim Brown - President, Chief Executive Officer WeiQi Lin - Executive Vice President of Research and Development, Principal Scientist Conference Call Participants Eli Merle - Cantor Fitzgerald Mayank Mamtani - FBR Francois Brisebois - Craig-Hallum Edwin Zhang - Stifel Ed Arce - H.C. Wainwright Operator Greetings and welcome and to the DURECT Corporati ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of inc ...

DURECT Corp (NASDAQ:DRRX) Q3 2019 Earnings Conference Call November 4, 2019 4:30 PM ET Company Participants Michael Arenberg - CFO James Brown - Co-Founder, CEO, President & Director WeiQi Lin - SVP, Research & Development Conference Call Participants Eliana Merle - Cantor Fitzgerald & Co. Adam Walsh - Stifel, Nicolaus & Company Antonio Arce - H.C. Wainwright & Co. Operator Greetings, and welcome and to the DURECT's Third Quarter Conference Call. [Operator Instructions]. Please note this conference is being ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of incorpor ...

DURECT Corporation (NASDAQ:DRRX) Q2 2019 Results Earnings Conference Call August 1, 2019 4:30 PM ET Company Participants Mike Arenberg - CFO Jim Brown - President and CEO Conference Call Participants Adam Walsh - Stifel Ed Arce - H.C. Wainwright and Co. François Brisebois - Laidlaw Doug Adams - Tocqueville Asset Management Operator Greetings and welcome to the DURECT Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to in ...

DURECT Corp, Inc. (NASDAQ:DRRX) Q1 2019 Earnings Conference Call May 8, 2019 8:30 AM ET Company Participants Michael Arenberg - CFO James Brown - Co-Founder, CEO, President & Director Paul Kwo - Professor, Medicine & Director, Hepatology, Stanford University Steven Flamm - Northwestern Tarek Hassanein - University of California Conference Call Participants Edwin Zhang - Stifel, Nicolaus & Company Antonio Arce - H.C. Wainwright & Co. Len Yaffe - Stoc*Doc Partners Operator Good day, and welcome to the DURECT ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of incorpo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-31615 DURECT CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3297098 (State or other jurisdiction of ...